#Capivasertib

Liz Johnson

wired4story

The past 8 years has seen a lot of targeted therapies for ER+ breast cancer.#MBCImpactNJ @komennewjersey Immunotherapy is being combined with CDK4/6 with some success in the lab. Not yet

Nuria Porta

NPortaStat

2020 has been challenging, so I want to end on a high note with all the publications I have contributed to this year #teamwork #stats #clinicaltrials @ICR_CTSU 1/12 Main

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.